Descriptive analyses of maternally-derived antibody levels against porcine circovirus 2 (PCV-2) in 3- and 21-day-old piglets from farms of four European countries using different vaccination protocols in sows
Abstract Background Up to now, information on the levels of maternally-derived antibodies (MDA) against PCV-2 in suckling piglets born to sows vaccinated with different strategies is scarce in the literature. In the present observational study, the PCV-2-specific MDA titres from piglets from 109 far...
Main Authors: | M. Sibila, A. Llorens, E. Huerta, C. Fablet, M. Faderl, L. Ferrari, N. Rose, A. Palzer, P. Martelli, M. C. Venegas-Vargas, D. Fredrickson, L. Taylor, M. Balasch, M. Bandrick, J. Segalés |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | Porcine Health Management |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40813-022-00284-9 |
Similar Items
-
Safety of the Administration of an Inactivated PCV2a/PCV2b/<i>Mycoplasma Hyopneumoniae</i> Vaccine to Pregnant and Lactating Sows and Gilts
by: Elena Pérez, et al.
Published: (2023-09-01) -
Frequency of Detection and Phylogenetic Analysis of <i>Porcine circovirus</i> <i>3</i> (PCV-3) in Healthy Primiparous and Multiparous Sows and Their Mummified Fetuses and Stillborn
by: Viviane Saporiti, et al.
Published: (2020-07-01) -
Genotyping of Porcine Circovirus 2 (PCV-2) in Vaccinated Pigs Suffering from PCV-2-Systemic Disease between 2009 and 2020 in Spain
by: Marina Sibila, et al.
Published: (2021-08-01) -
Revisiting Porcine Circovirus Disease Diagnostic Criteria in the Current <i>Porcine Circovirus 2</i> Epidemiological Context
by: Joaquim Segalés, et al.
Published: (2022-03-01) -
Efficacy Studies of a Trivalent Vaccine Containing PCV-2a, PCV-2b Genotypes and <i>Mycoplasma hyopneumoniae</i> When Administered at 3 Days of Age and 3 Weeks Later against Porcine Circovirus 2 (PCV-2) Infection
by: Patricia Pleguezuelos, et al.
Published: (2022-08-01)